EV1000 Clinical Platform Non-Invasive (NI) or ClearSight System, EV1000 Clinical Platform
K-Number: K203131 · 2021-01-22
Device Summary
Frequently Asked Questions
What is the EV1000 Clinical Platform Non-Invasive (NI) or ClearSight System, EV1000 Clinical Platform?
EV1000 Clinical Platform Non-Invasive (NI) or ClearSight System, EV1000 Clinical Platform is a medical device that received FDA 510(k) clearance on 2021-01-22. It is manufactured by Edwards Lifesciences, LLC. The 510(k) number is K203131.
When was EV1000 Clinical Platform Non-Invasive (NI) or ClearSight System, EV1000 Clinical Platform approved by the FDA?
EV1000 Clinical Platform Non-Invasive (NI) or ClearSight System, EV1000 Clinical Platform received FDA 510(k) clearance on 2021-01-22, under approval number K203131.
What company makes EV1000 Clinical Platform Non-Invasive (NI) or ClearSight System, EV1000 Clinical Platform?
EV1000 Clinical Platform Non-Invasive (NI) or ClearSight System, EV1000 Clinical Platform is manufactured by Edwards Lifesciences, LLC.
What is the FDA product code for EV1000 Clinical Platform Non-Invasive (NI) or ClearSight System, EV1000 Clinical Platform?
The FDA product code for EV1000 Clinical Platform Non-Invasive (NI) or ClearSight System, EV1000 Clinical Platform is DXN.
Related Clinical Trials
Related PubMed Literature
Other Devices by Edwards Lifesciences, LLC
Related Devices (Code: DXN)
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.